Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups

BACKGROUND: Bevacizumab has an important role in first-line treatment of metastatic colorectal cancer. However, clinical trials studying its effect have involved distinct chemotherapy regimens with divergent results. The aim of this meta-analysis is to gather current data and evaluate not only the e...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Macedo, Ligia Traldi, da Costa Lima, Andre Bacellar, Sasse, Andre Deeke
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2012
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3350458/
https://ncbi.nlm.nih.gov/pubmed/22414244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-89
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky